Toggle menu

CERA

Start date:
18/3/2020
Co-ordinated by:
TERN

COVID-19 has recently created a public health emergency and has been declared a pandemic by the World Health Organization. There are serious concerns regarding surge capacity of UK facilities to cope with a pandemic illness and it is conceivable that the psychological, emotional and physical demands placed on an already overstretched workforce may be substantial.

The CERA study aims to understand the evolving and cumulative effects of working during the COVID-19 outbreak on the psychological health of those physicians working in the emergency care settings across the UK.  Physicians will be asked to complete questionnaires on their phones at 3 different time scales; during the Acceleration phase (beginning), during the Peak phase (middle) and during the Deceleration phase (end). It is anticipated that this study will enhance future pandemic preparedness, by highlighting staff resilience and tolerance, and where further support – delivered either during or after an incident – may be beneficial.

The study itself is a TERN project with the support of EMERGE.

Local PI

Research Team

Emma Moatt

Research Project Manager

Emily Godden

Senior Research Nurse - Renal/Acute Medicine

Fraser Craig

Clinical Trial Assistant

More EMERGE Trials

Assisting in identifying patients with Humeral shaft fractures in the ED by screening.

Giving patient information sheets to introduce the study, so patient has had adequate time to read and make decision about going into the trial before going to the fracture clinic.

Read more

HU-FIX Trial

ISARIC4C – Coronavirus Clinical Characterisation Consortium, an observational study

ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)

TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.

Read more

TARGET-CTCA Trial